mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0004 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.005 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |